BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 […]
Category Archives: Pr Newswire
18
Feb
Feb
NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) — Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET. A webcast of the […]
18
Feb
Feb
TORONTO and HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases is pleased to announce its participation in several upcoming conferences. These events provide an opportunity for Medicenna to showcase […]
Pr Newswire
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
18
Feb
Feb
ASCEND to evaluate CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types, including NSCLC and gastrointestinal and gynecological cancers in first-line and previously treated patients Company anticipates reporting proof-of-concept data in the first quarter of 2027 ASCEND is the first of four clinical trials across the portfolio expected to initiate in 2026 […]
18
Feb
Feb
VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced that Adam Rogers, MD, President and Chief Executive Officer of NervGen, and other members […]
KUALA LUMPUR, Malaysia, Feb. 18, 2026 /PRNewswire/ — A report from Shandian News. A nationwide celebration The 2026 Shandong Spring Festival Gala will be broadcast on Shandong TV on February 15 (the 28th day of the Chinese lunar calendar). This year, an overseas sub-venue has been specially unveiled in Malaysia. Through songs, dances, interviews, and displays […]
Milo continues to lead crypto lending, supporting digital asset holders with flexible financing options for home purchases and beyond. MIAMI, Feb. 18, 2026 /PRNewswire/ — Milo, a financial technology company and pioneer in crypto lending, today announced it has originated over $100 million in crypto mortgages, representing significant growth in institutional and high net worth […]
New R&D Center, to be located in Yokohama’s Minato Mirai 21 district, is scheduled to begin operations in April 2026, with the official inauguration in the first half 2027 Jan Fallgren appointed Head of Ericsson Radio R&D in Japan. Recruitment underway for up to 300 R&D positions The facility will advance radio technology, foster ecosystem […]
The recognition highlights Bioiberica’s science-led innovation, clinical differentiation, and manufacturing excellence in the European innovative collagen market. SAN ANTONIO, Feb. 18, 2026 /PRNewswire/ — Frost & Sullivan is pleased to announce that Bioiberica has received the 2025 European New Product Innovation Recognition in the innovative collagen solutions industry for its outstanding achievements in clinical validation, ingredient differentiation, […]
The Telkom-backed VC reinforces cross-sector partnerships and compliance standards to unlock scalable portfolio growth across Indonesia’s state-linked ecosystem. JAKARTA, Indonesia, Feb. 18, 2026 /PRNewswire/ — After investing across the AI, cybersecurity, and blockchain sectors through portfolio companies such as Cyfirma, Whale, and IDRX throughout 2025, MDI Ventures is now sharpening its strategic focus on maximizing […]